{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:01:49Z","timestamp":1769169709862,"version":"3.49.0"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Knee Surg Sports Traumatol Arthrosc"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00167-019-05598-w","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T18:16:31Z","timestamp":1562264191000},"page":"408-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee"],"prefix":"10.1002","volume":"28","author":[{"given":"Fabio","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad A.","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-9944","authenticated-orcid":false,"given":"Norbert","family":"Suhm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"5598_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S8756-3282(03)00164-9","volume":"33","author":"CE Berger","year":"2003","unstructured":"Berger CE, Kr\u00f6ner AH, Minai-Pour MB, Ogris E, Engel A (2003) Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone 33:346\u2013351","journal-title":"Bone"},{"issue":"5","key":"5598_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4158\/EP161638.OR","volume":"24","author":"C Crotti","year":"2018","unstructured":"Crotti C, Watts NB, De Santis M, Ceribelli A, Fabbriciani G et al (2018) Acute phase reactions after zoledronic acid infusion: protective role of 25-hydroxyvitamin D and previous oral bisphosphonate therapy. Endocr Pract. 24(5):405\u2013410","journal-title":"Endocr Pract."},{"key":"5598_CR3","first-page":"755","volume":"25","author":"EF Eriksen","year":"2015","unstructured":"Eriksen EF (2015) Treatment of bone marrow lesions (bone marrow edema). BoneKEy Rep 25:755","journal-title":"BoneKEy Rep"},{"issue":"1","key":"5598_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15360288.2016.1276993","volume":"31","author":"BJ Flores-Robles","year":"2017","unstructured":"Flores-Robles BJ, Sanz-Sanz J, Sanabria-Sanchinel AA, Huntley-Pascual D, Andr\u00e9u S\u00e1nchez JL et al (2017) Zoledronic acid treatment in primary bone marrow edema syndrome. J Pain Palliat Care Pharmacother 31(1):52\u201356","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"5598_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/1071100717697427","volume":"38","author":"K Horas","year":"2017","unstructured":"Horas K, Fraissler L, Maier G, Jakob F, Seefried L, Konrads C, Rudert M, Walcher M (2017) High prevalence of vitamin D deficiency in patients with bone marrow edema syndrome of the foot and ankle. Foot Ankle Int 38:760\u2013766","journal-title":"Foot Ankle Int"},{"key":"5598_CR6","first-page":"7829","volume":"103","author":"KL Kavanagh","year":"2006","unstructured":"Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RGG, Oppermann U (2006) The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Med Sci 103:7829\u20137834","journal-title":"Med Sci"},{"key":"5598_CR7","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00167-016-4113-2","volume":"24","author":"E Kon","year":"2016","unstructured":"Kon E, Ronga M, Filardo G, Farr J, Madry H, Milano G, Andriolo L, Shabshin N (2016) Bone marrow lesions and subchondral bone pathology of the knee. Knee Surg Sports Traumatol Arthrosc 24:1797\u20131814","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"5598_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","volume":"71","author":"LL Laslett","year":"2012","unstructured":"Laslett LL, Dor\u00e9 DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, Jones G (2012) Zoledronic acid reduces knee pain and bone marrow lesions over 1\u00a0year: a randomised controlled trial. Ann Rheum Dis 71:1322\u20131328","journal-title":"Ann Rheum Dis"},{"key":"5598_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1302\/2058-5241.1.000044","volume":"1","author":"M Marcacci","year":"2016","unstructured":"Marcacci M, Andriolo L, Kon E, Shabshin N, Filardo G (2016) Aetiology and pathogenesis of bone marrow lesions and osteonecrosis of the knee. EFORT Open Rev 1:219\u2013224","journal-title":"EFORT Open Rev"},{"key":"5598_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00198-013-2581-5","volume":"25","author":"C Meier","year":"2014","unstructured":"Meier C, Kraenzlin C, Friederich NF, Wischer T, Grize L, Meier CR, Kraenzlin ME (2014) Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial. Osteoporos Int 25:359\u2013366","journal-title":"Osteoporos Int"},{"key":"5598_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009416.pub2","author":"NE O\u2019Connell","year":"2013","unstructured":"O\u2019Connell NE, Wand BM, McAuley J, Marston L, Moseley GL (2013) Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. \nhttps:\/\/doi.org\/10.1002\/14651858.CD009416.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"5598_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12891-018-2379-x","volume":"19","author":"N Oehler","year":"2018","unstructured":"Oehler N, Mussawy H, Schmidt T, Rolvien T, Barvencik F (2018) Identification of vitamin D and other bone metabolism parameters as risk factors for primary bone marrow oedema syndrome. BMC Musculoskelet Disord 19:451","journal-title":"BMC Musculoskelet Disord"},{"key":"5598_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.joca.2003.11.003","volume":"12","author":"CG Peterfy","year":"2004","unstructured":"Peterfy CG, Guermazi A, Zaim S, Tirman PFJ, Miaux Y, White D, Kothari M, Lu Y, Fye K, Zhao S, Genant HK (2004) Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthr Cartil 12:177\u2013190","journal-title":"Osteoarthr Cartil"},{"key":"5598_CR14","first-page":"766","volume":"25","author":"JD Ringe","year":"2007","unstructured":"Ringe JD, Brody J-J (2007) Review a review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover. Clin Exp Rheumatol 25:766\u2013774","journal-title":"Clin Exp Rheumatol"},{"key":"5598_CR15","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00198-005-2001-6","volume":"16","author":"JD Ringe","year":"2005","unstructured":"Ringe JD, Dorst A, Faber H (2005) Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporos Int 16:2063\u20132068","journal-title":"Osteoporos Int"},{"key":"5598_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.injury.2017.02.020","volume":"48","author":"T Rolvien","year":"2017","unstructured":"Rolvien T, Schmidt T, Butscheidt S, Amling M, Barvencik F (2017) Denosumab is effective in the treatment of bone marrow oedema syndrome. Injury 48:874\u2013879","journal-title":"Injury"},{"key":"5598_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/cmdc.200500059","volume":"1","author":"J-M Rondeau","year":"2006","unstructured":"Rondeau J-M, Bitsch F, Bourgier E, Geiser M, Hemmig R, Kroemer M, Lehmann S, Ramage P, Rieffel S, Strauss A, Green JR, Jahnke W (2006) Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. ChemMedChem 1:267\u2013273","journal-title":"ChemMedChem"},{"key":"5598_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.injury.2014.01.023","volume":"45","author":"MJK Simon","year":"2014","unstructured":"Simon MJK, Barvencik F, Luttke M, Amling M, Mueller-Wohlfahrt H-W, Ueblacker P (2014) Intravenous bisphosphonates and vitamin D in the treatment of bone marrow oedema in professional athletes. Injury 45:981\u2013987","journal-title":"Injury"},{"key":"5598_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3113\/FAI.2011.0508","volume":"32","author":"AE Sprinchorn","year":"2011","unstructured":"Sprinchorn AE, O\u2019Sullivan R, Beischer AD (2011) Transient bone marrow edema of the foot and ankle and its association with reduced systemic bone mineral density. Foot Ankle Int 32:508\u2013512","journal-title":"Foot Ankle Int"},{"key":"5598_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejrad.2008.01.056","volume":"67","author":"WA Thiryayi","year":"2008","unstructured":"Thiryayi WA, Thiryayi SA, Freemont AJ (2008) Histopathological perspective on bone marrow oedema, reactive bone change and haemorrhage. Eur J Radiol 67:62\u201367","journal-title":"Eur J Radiol"},{"key":"5598_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420","journal-title":"Osteoporos Int"}],"container-title":["Knee Surgery, Sports Traumatology, Arthroscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00167-019-05598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00167-019-05598-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00167-019-05598-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:24:24Z","timestamp":1702668264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00167-019-05598-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5598"],"URL":"https:\/\/doi.org\/10.1007\/s00167-019-05598-w","relation":{},"ISSN":["0942-2056","1433-7347"],"issn-type":[{"value":"0942-2056","type":"print"},{"value":"1433-7347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No external funding was received.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This study was approved by the regional ethics committee on research involving humans (ID: EKNZ no. 2017-00338).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Due to the retrospective design, no informed consent was obtained. This was specifically approved by the ethics committee prior to the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}